Search / Trial NCT06232499

Effects of Intravenous Laser Irradiation of Blood Treatment With Different Colored Lights on Controlling Recurrent Stroke Risk Factors and Neurological Function in Stroke Patients

Launched by TAIPEI HOSPITAL, MINISTRY OF HEALTH AND WELFARE · Jan 22, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Stroke Intravenous Laser Irradiation Of Blood Recurrent Stroke Risk Factors

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Diagnosed as a first-time stroke patient.
  • 2. Onset of illness within 6 months of enrollment.
  • 3. Recruitment period from January to December of the year 113.
  • 4. All participants or their legal representatives must sign the informed consent form.
  • Exclusion Criteria:
  • 1. Skin diseases that make injection or photosensitivity unsuitable.
  • 2. Pregnancy and abnormal blood clotting function.
  • 3. Presence of a cardiac pacemaker.
  • 4. Inability to comply with the 5-month study plan.

About Taipei Hospital, Ministry Of Health And Welfare

Taipei Hospital, under the Ministry of Health and Welfare of Taiwan, is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. With a commitment to enhancing patient outcomes and public health, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experts to conduct rigorous clinical studies across various therapeutic areas. As a sponsor, Taipei Hospital prioritizes ethical standards, patient safety, and scientific integrity, contributing valuable insights to the global medical community and fostering collaboration to address pressing health challenges.

Locations

New Taipei City, Roc, Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0